A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older

Phase 3 Completed 55 enrolled UMN Pharma Inc.

Non-randomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to confirm the safety until Day 29 after injection of a single dose of quadrivalent vaccine ASP7374 in adult subjects aged 20 or older

Timeline

Start: 2015-02
Primary completion: 2015-04
Completion: 2015-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ASP7374	Vaccine	—	Subcutaneous

A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older

Summary

Timeline

Drugs

Indications